The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...
SoluPet, the data and science-driven pet cognitive health company developing advanced cognitive-aging support for senior dogs ...
Bucheerei’s appointment comes at a pivotal time as Ithmaar Bank advances its comprehensive restructuring and transformation programme aimed at strengthening its business model ...
Joint presentation by Orchestra BioMed and Medtronic leadership to discuss ongoing strategic collaboration for development and commercialization ...
ADM’s Claudia Faustina, product manager for Sweet Food Human Nutrition, shares how 2026 Flavor & Color Trends are reshaping ...
The Nutraceutical Excipients Market was valued at USD 4.5 billion in 2024, reflecting strong expansion driven by the rising consumption of dietary supplements and functional nutrition products. As ...
High-level events are always very helpful, not just for the formal agreements reached, but for the quiet behind-the-scenes ...
Mumbai: Platinum Industries Ltd. (BSE: 544134; NSE: PLATIND), a leading manufacturer of PVC & CPVC additives, has further reinforced its ...
The global market growth is accelerating as modernization, automation, and rising demand for value-added dairy products are driving the equipment upgrades through 2030.Hyderabad, India, Dec. 08, 2025 ...
The Hubbis Asian Private Wealth Management Year-End Review 2024 Serene Liaw is the Deputy Director of Strategic Planning & ...
Corona Remedies' IPO is now open for subscription. The company is offering shares at a price band of Rs 1,008 to Rs 1,062.
Detailed price information for Ventyx Biosciences Inc (VTYX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback